|
SBDS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.041960E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.816160E-02 |
| Normal-vs-Stage2 |
3.109900E-02 |
| Normal-vs-Stage3 |
7.179400E-03 |
| Normal-vs-Stage4 |
9.560400E-02 |
| Stage1-vs-Stage2 |
6.177000E-01 |
| Stage1-vs-Stage3 |
4.694000E-01 |
| Stage1-vs-Stage4 |
9.626600E-01 |
| Stage2-vs-Stage3 |
9.801200E-01 |
| Stage2-vs-Stage4 |
6.879800E-01 |
| Stage3-vs-Stage4 |
5.987600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.341650E-02 |
| Normal-vs-AfricanAmerican |
6.263000E-01 |
| Normal-vs-Asian |
3.744500E-02 |
| Caucasian-vs-AfricanAmerican |
2.589800E-01 |
| Caucasian-vs-Asian |
7.434000E-01 |
| AfricanAmerican-vs-Asian |
2.773200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.737100E-03 |
| Normal-vs-Female |
2.638100E-02 |
| Male-vs-Female |
2.162000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.322300E-02 |
| Normal-vs-Age(41-60Yrs) |
5.735300E-03 |
| Normal-vs-Age(61-80Yrs) |
2.061900E-02 |
| Normal-vs-Age(81-100Yrs) |
3.581400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.086200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.724800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.743400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.127800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.623800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.099400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.212200E-01 |
| Classical-VS-Follicular |
1.314410E-02 |
| Classical-VS-Other |
8.134400E-02 |
| Classical-VS-Normal |
7.250300E-02 |
| Tall-VS-Follicular |
1.418640E-01 |
| Tall-VS-Other |
1.091380E-01 |
| Tall-VS-Normal |
2.799200E-01 |
| Follicular-VS-Other |
4.128400E-01 |
| Follicular-VS-Normal |
2.435300E-03 |
| Other-VS-Normal |
2.931900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.539800E-03 |
| Normal-vs-N1 |
8.051600E-02 |
| N0-vs-N1 |
4.645600E-01 |
|
|
